CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-02 | Spurr Robert U.S. President-Pharma Business | Grant or award · Non-Qualified Stock Options (right to purchase) | +131,910 | 131,910 | ||
| 2022-03-01 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Sale | −6,338 | $23.82 | $151K | 112,179 |
| 2022-02-28 | PAPA JOSEPH C Chairman & CEO | Shares withheld for taxes | −5,115 | $24.06 | $123K | 1,107,795 |
| 2022-02-27 | PAPA JOSEPH C Chairman & CEO | Option exercise | +208,231 | 1,239,650 | ||
| 2022-02-27 | PAPA JOSEPH C Chairman & CEO | Shares withheld for taxes | −100,351 | $24.35 | $2.4M | 1,139,299 |
| 2022-02-27 | PAPA JOSEPH C Chairman & CEO | Shares withheld for taxes | −13,206 | $24.35 | $322K | 1,112,910 |
| 2022-02-27 | PAPA JOSEPH C Chairman & CEO | Grant or award · Restricted Share Units | +208,231 | 0 | ||
| 2022-02-27 | PAPA JOSEPH C Chairman & CEO | Option exercise · Restricted Share Units | −208,231 | $24.35 | $5.1M | 0 |
| 2022-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Option exercise | +17,350 | 127,988 | ||
| 2022-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −6,233 | $24.35 | $152K | 121,755 |
| 2022-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −1,716 | $24.35 | $42K | 118,517 |
| 2022-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award · Restricted Share Units | +17,350 | 0 | ||
| 2022-02-27 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Option exercise · Restricted Share Units | −17,350 | $24.35 | $422K | 0 |
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Option exercise | +24,292 | 341,517 | ||
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −8,782 | $24.35 | $214K | 332,735 |
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −2,402 | $24.35 | $58K | 328,141 |
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Grant or award · Restricted Share Units | +24,292 | 0 | ||
| 2022-02-27 | APPIO THOMAS CEO, Pharma Business | Option exercise · Restricted Share Units | −24,292 | $24.35 | $592K | 0 |
| 2022-02-27 | Spurr Robert U.S. President-Pharma Business | Option exercise | +15,615 | 75,914 | ||
| 2022-02-27 | Spurr Robert U.S. President-Pharma Business | Shares withheld for taxes | −5,646 | $24.35 | $137K | 70,268 |
Page 16 of 23 · 453 trades